loader image
Saturday, May 18, 2024
82.9 F
McAllen
We Welcome your Press Release
- Advertisement -

Drug Shows Promising Results for Serious Heart Condition

Translate to Spanish or other 102 languages!

A Medication used in a clinical trial is showing some promising results for people with hypertrophic cardiomyopathy, or HCM for short. Image for illustration purposes
A Medication used in a clinical trial is showing some promising results for people with hypertrophic cardiomyopathy, or HCM for short. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC –A Medication used in a clinical trial is showing some promising results for people with hypertrophic cardiomyopathy, or HCM for short.

The disease, which causes abnormal thickening of the heart muscle, affects between 15 and 20 million people worldwide.

“Common symptoms are shortness of breath, dizziness with exertion and lightheadedness. Occasionally, they may have chest pain and passing out, commonly with exertion or due to arrhythmias,” explained Milind Desai, MD, cardiologist for Cleveland Clinic and principal investigator for the clinical trial.

- Advertisement -

Dr. Desai said they wanted to explore newer medical therapies for patients with HCM, so they decided to test the medication “Mavacamten.”

Based on the results, it appears to be an effective form of treatment for those who would have otherwise needed an invasive procedure.

Dr. Desai said patients who took the medication reported an improvement in symptoms and quality of life.

“This disease has been barely recognized for about 60 odd years, so the evolution of diagnostic techniques in this disease, the evolution of invasive techniques in this disease and now the evolution of precision medications in this disease is huge if you take the spectrum of time we are talking about,” said Dr. Desai.

- Advertisement -

The medication used in the trial is currently awaiting approval from the FDA.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Imaging Software Improves Lung Diagnosis For 30% Of Patients Who Can’t Tolerate Contrast Dye

As a result, the software program helps doctors and researchers get consistent patient data, leading to better diagnoses and specifics on where to target potential therapies - all without contrast dye.

Moms Club Event Focused on Maternal Mental Health 

A study found that maternal mental health conditions such as depression and anxiety disorders affected 13.2% of Texas mothers.

Final Nursing Home Staffing Rule Would Require 102,000 Additional Caregivers, Cost $6.5B Per Year

The AHCA/NCAL analysis of the final rule uses staffing, cost, and facility data from the federal government: CMS' Payroll Based Journal, Medicare Cost Reports, and Care Compare. 

Pharr EMS:  Learn Lifesaving Procedures & Tour EMS Headquarters, May 23rd

The Stop the Bleed event aims to empower individuals with the knowledge and skills to assist in a bleeding emergency before professional help arrive
- Advertisement -
×